← back to search

Torbjörn Lundström

AstraZeneca (Poland) · SE
Area of research
Cardiology and Cardiovascular Medicine · Equine
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Veterinary Equine Medical Research, Venous Thromboembolism Diagnosis and Management, and Fatty Acid Research and Health.
h-index
17
citations
2,707
works
43
NIH funding
—
primary concept
Medicine
email
torbjorn@djurtandvardskliniken.se

Recent publications

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
JAMA 2020cited by 972position: middledoi
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
Clinical Cardiology 2018cited by 167position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paul M. Ridker · Gentofte Hospital2 papers (2018–2020)Michael H. Davidson · Royal Marsden Hospital2 papers (2018–2020)Dianna Bash · Center for Clinical Research (United States)2 papers (2018–2020)Steven E. Nissen · Cleveland Clinic2 papers (2018–2020)A. Michael Lincoff · Cleveland Clinic2 papers (2018–2020)Kausik K. Ray · Imperial College London2 papers (2018–2020)Philip J. Barter · Nuffield Health2 papers (2018–2020)Wolfgang Köenig · Zimmer Biomet (United States)2 papers (2018–2020)Christie M. Ballantyne · New York University2 papers (2018–2020)Stephen J. Nicholls · Australian Regenerative Medicine Institute2 papers (2018–2020)Dariush Mozaffarian · Tufts Medical Center2 papers (2018–2020)Darren K. McGuire · Saint Luke's Health System2 papers (2018–2020)John J.P. Kastelein · QRx Pharma (United States)2 papers (2018–2020)Rahul Agrawal · University of Utah1 papers (2020–2020)— · 1 papers (2018–2018)Michelle Garcia · Innovation Cluster (Canada)1 papers (2020–2020)Brian G. Katona · AstraZeneca (United States)1 papers (2020–2020)Kathy Wolski · Cleveland Clinic1 papers (2020–2020)Terje R. Pedersen · University of Oslo1 papers (2018–2018)Martin Rensfeldt · AstraZeneca (Spain)1 papers (2020–2020)